Author： Rao M.R. Blackwelder W.C. Troendle J.F. Naficy A.B. Clemens J.D.
Publisher： Elsevier
ISSN： 0264-410X
Source： Vaccine, Vol.20, Iss.27, 2002-09, pp. : 3364-3369
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines
By Ravenscroft N. Averani G. Bartoloni A. Berti S. Bigio M. Carinci V. Costantino P. D'Ascenzi S. Giannozzi A. Norelli F. Pennatini C. Proietti D. Ceccarini C. Cescutti P.
Vaccine, Vol. 17, Iss. 22, 1999-07 ,pp. :
Access to resources
Recommend
The introduction of new vaccines into developing countries II. Vaccine financing
By Mahoney R.T. Ramachandran S. Xu Z.-Y.
Vaccine, Vol. 18, Iss. 24, 2000-06 ,pp. :
By Gilbert P.B. Chiu Y.-L. Allen M. Lawrence D.N. Chapdu C. Israel H. Holman D. Keefer M.C. Wolff M. Frey S.E. NIAID HIV Vaccine Trials Network
Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. :
By Chen Wen-Hung Lenderking William Jin Ying Wyrwich Kathleen Gelhorn Heather Revicki Dennis
Quality of Life Research, Vol. 23, Iss. 2, 2014-03 ,pp. :